氟-18 市场分析及预测(按规模、份额、增长、趋势)2030

  • Report Code : TIPRE00038973
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

 

[研究报告] 氟-18 市场预测可以帮助该市场的利益相关者概述其增长战略。预计该市场将从 2022 年的 17.2 亿美元增长到 2030 年的 24.1 亿美元;预计 2022-2030 年的复合年增长率为 4.3%。

 

市场洞察和分析师观点:

氟-18 是一种用于医疗诊断程序的放射性同位素,是全球最常用的医用放射性同位素之一。它具有良好的正电子发射特性,半衰期为 109.8 分钟。慢性病患病率高和核成像技术使用增加等因素推动了氟-18 市场的增长。然而,氟-18 的保质期短阻碍了市场的增长。此外,放射性示踪剂在癌症诊断中的应用预计将在未来几年带来新的氟-18市场趋势。

 

增长动力:

 

核成像技术的广泛应用推动市场增长

先进的辐射技术为诊断和核医学、放射治疗和介入放射学开辟了新视野。电离辐射在诊断和治疗中的应用使全球数百万患者受益。正电子发射断层扫描 (PET) 是临床环境中常用的核医学放射学检查方式,因为它有助于准确检测、定位和表征疾病。根据世界卫生组织 (WHO) 的数据,全球每年进行超过 36 亿次放射学诊断检查、3700 万次核医学程序和 750 万次放射治疗。根据欧盟委员会的数据,欧洲每年使用放射性药物和成像仪器进行约 1000 万次核医学程序,以诊断疾病并进行针对性治疗。这些技术还被应用于肿瘤学、免疫学、感染研究、胃肠病学、心脏病学、神经病学和精神病学。 PET/CT 新型放射性药物的开发和推出,以及不同肿瘤分期方法的准确性不断提高,促进了氟-18 市场的增长。例如,新推出的心脏放射性药物(如氟吡达唑 F-18)有助于更精确地对心血管疾病进行成像。

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

氟-18 市场:

Fluorine-18 Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

报告细分和范围:

氟-18 市场分析考虑了以下几个部分:产品类型、应用和最终用户。按产品类型,市场细分为 FDG、NaF 和其他。FDG 部分在 2022 年占据氟-18 最大的市场份额,预计在预测期内将实现最高的复合年增长率。FDG, NaF, and others. The FDG segment held the largest fluorine-18 market share in 2022 and it is anticipated to register the highest CAGR during the forecast period.

氟-18 市场按应用分为肿瘤学、心脏病学、神经病学和其他。肿瘤学领域在 2022 年占据最大的市场份额,预计在预测期内将实现最高的复合年增长率。

根据最终用户,市场分为医院、诊断中心和其他。医院部门在 2022 年占据了氟-18 最大的市场份额。预计在预测期内将录得最高的复合年增长率。

 

区域分析:

就地理范围而言,氟-18 市场报告的范围包括北美、欧洲、亚太地区、南美和中美以及中东和非洲。2022 年,北美占据了最大的市场份额。由于混合成像等技术的进步、用于诊断和治疗的新型放射性药物的引入以及基于示踪剂原理的分子成像技术的发展,美国的核医学取得了显着增长。获得先进的医疗保健基础设施、目标疾病发病率和患病率的上升以及主要参与者的产品创新进一步促进了北美氟-18 市场规模的扩大。根据国际癌症研究机构(IARC)的数据,美国癌症病例数预计将从2020年的228万例增加到2040年的312万例。此外,美国医疗保险和医疗补助服务中心(CMS)已根据《临床实验室改进修正案》(CLIA)采用了与人体实验室研究相关的标准,有利于市场的发展。

 

行业发展和未来机遇:

以下列出了氟-18 市场主要参与者的一些战略发展:

  • 2023 年 10 月,Blue Earth Diagnostics Ltd 与 Sinotau Pharmaceutical Group 签署了 flotufolastat (18F) 注射剂(以前称为 18F-rhPSMA-7.3)的独家战略协议。根据协议条款,两家公司成为紧密的战略合作伙伴,联手为患有前列腺癌的中国男性提供 PET 成像剂 flotufolastat (18F) 的分销提供技术和监管支持。此事件标志着 Blue Earth Diagnostics 向全球患者和临床医生提供 flotufolastat (18F) 的战略进入重要阶段。
  • 2023 年 7 月,欧盟委员会批准 Curium 公司生产的创新型 18F-PSMA PET 示踪剂 Pylclari 上市销售,用于在临床环境中使用 PET 检测患有前列腺癌的成年人的 PSMA 阳性(即前列腺特异性膜抗原)病变。
  • 2023 年 5 月,Blue Earth Diagnostics 的优化高亲和力放射性杂交 (rh) PSMA 靶向 PET 显像剂——POSLUMA (flotufolastat F 18) 注射剂(以前称为 18F-rhPSMA-7.3)获得美国食品药品监督管理局 (FDA) 批准。POSLUMA 用于通过 PET 检测前列腺癌患者的 PSMA 阳性病变,根据血清前列腺特异性抗原 (SA) 水平升高怀疑有转移或复发。转移性患者被视为初始确定性治疗的候选人。POSLUMA 是第一个也是唯一一个获得 FDA 批准的采用专有 rh 技术开发的 PSMA 靶向显像剂。它于 2023 年 6 月通过 Blue Earth Diagnostics 全国放射性药物网络中的某些放射性药物进行商业化销售,该网络由其来自美国的商业制造商和分销商组成。
  • 2021 年 5 月,Lantheus Holdings, Inc. 获得 FDA 批准,PYLARIFY 是一种氟 18 标记的 PSMA 靶向 PET 成像剂,用于识别前列腺癌的疑似转移或复发。PYLARIFY 是首个也是唯一一个获得 FDA 批准的用于前列腺癌的商业化 PSMA PET 成像剂。

 

 

氟-18 市场区域洞察

Insight Partners 的分析师已详细解释了预测期内影响氟-18 市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的氟-18 市场细分和地理位置。

Fluorine-18 Market
  • 获取氟-18 市场的区域具体数据

氟-18市场报告范围

报告属性细节
2022 年市场规模17.2亿美元
2030 年的市场规模24.1亿美元
全球复合年增长率(2022 - 2030 年)4.3%
史料2020-2022
预测期2022-2030
涵盖的领域按产品类型
  • 脱氧葡萄糖
  • 氟化钠
按应用
  • 肿瘤学
  • 心脏病学
  • 神经病学
按最终用户
  • 医院
  • 诊断中心
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  •  
  • 西门子医疗
  • 兰瑟斯医学影像公司
  • 诺华公司
  • 康德乐
  • 通用电气医疗集团
  • 欢庆放射药物公司
  • 礼来公司
  • 核子科技研究工业有限公司
  • 库里姆制药公司

 

氟-18 市场参与者密度:了解其对业务动态的影响

氟-18 市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在氟-18 市场运营的主要公司有:

  1. 西门子医疗
  2. 兰瑟斯医学影像公司
  3. 诺华公司
  4. 康德乐
  5. 通用电气医疗集团

免责声明上面列出的公司没有按照任何特定顺序排列。


Fluorine-18 Market

 

  • 获取氟-18 市场顶级关键参与者概览

 

竞争格局和重点公司:

西门子医疗、Lantheus Medical Imaging Inc、诺华公司、Cardinal Health、通用电气医疗、Jubilant Radiopharma、礼来公司、Nukleon 核技术研究工业有限公司、Curium Pharma 和 Blue Earth Diagnostics Inc 是氟-18 市场报告中介绍的知名公司。这些公司专注于开发新技术、升级现有产品并扩大其地理覆盖范围,以满足全球日益增长的消费者需求。

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is fluorine-18?

Fluorine-18 is a fluorine radioisotope used in medical diagnostic procedures and is among the most commonly used medical radioisotopes globally. Fluorine-18 has good positron-emitting properties and a half-life of 109.8 min.

What factors drive the fluorine-18 market?

Factors such as the high prevalence of chronic diseases and increasing use of nuclear imaging techniques propel the fluorine-18 market growth.

What was the estimated fluorine-18 market size in 2022?

The fluorine-18 market was valued at US$ 1,720.71 million in 2022.

Who are the major players in the fluorine-18 market?

The fluorine-18 market majorly consists of the players, including Siemens Healthineers, Lantheus Medical Imaging Inc, Novartis AG, Cardinal Health, GE HealthCare, Jubilant Radiopharma, Eli Lilly and Company, Nukleon Nuclear Technology Research Ind Co Ltd, Curium Pharma, and Blue Earth Diagnostics Inc.

What are the growth estimates for the fluorine-18 market till 2030?

The fluorine-18 market is expected to be valued at US$ 2,415.67 million in 2030.

Which product type segment dominates the fluorine-18 market?

By product type, the fluorine-18 market is segmented into FDG, NaF, and others. The FDG segment held the largest fluorine-18 market share in 2022 and it is anticipated to register the highest CAGR during the forecast period.

Which end users segment dominates the fluorine-18 market?

The fluorine-18 market, by end users, is categorized into hospitals, diagnostic centers, and others. The hospitals segment held the largest market share in 2022 and is anticipated to register the highest CAGR during the forecast period.

Which application segment dominates the fluorine-18 market?

The fluorine-18 market, by application, is divided into oncology, cardiology, neurology, and others. The oncology segment held a larger market share in 2022 and is anticipated to register a higher CAGR during the forecast period.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies - Fluorine-18 Market

  1. Siemens Healthineers
  2. Lantheus Medical Imaging Inc
  3. Novartis AG
  4. Cardinal Health
  5. GE HealthCare
  6. Jubilant Radiopharma
  7. Eli Lilly and Company
  8. Nukleon Nuclear Technology Research Ind Co Ltd
  9. Curium Pharma
  10. Blue Earth Diagnostics Inc

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.